Estrogen receptor ligands ameliorate fatty liver through a nonclassical estrogen receptor/Liver X receptor pathway in mice
Song‐iee Han, Yoko Komatsu, Akiko Murayama, Knut R. Steffensen, Yoshimi Nakagawa, Yuka Nakajima, Michiko Suzuki, Shohei Oie, Paolo Parini, Lise‐Lotte Vedin, Hiroyuki Kishimoto, Hitoshi Shimano, Jan‐Åke Gustafsson, Junn Yanagisawa – 26 November 2013 – Liver X receptor (LXR) activation stimulates triglyceride (TG) accumulation in the liver. Several lines of evidence indicate that estradiol‐17β (E2) reduces TG levels in the liver; however, the molecular mechanism underlying the E2 effect remains unclear.